V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20220689 | 20175296 | 1.7 | 78 | Curative (C) | 2016-03-01 | 2016-03-02 | EOX | 02 | Y | SORAFENIB | 100739337 |
| 20220714 | 20175297 | 1.66 | 85.5 | Palliative (P) | 2020-09-25 | 2020-09-25 | EOX | 02 | N | CAPECITABINE + RT | 101248078 |
| 20220715 | 20175298 | 1.53 | 62.1 | null | 2021-01-20 | 2021-03-07 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | null | CETUXIMAB + IRINOTECAN + MDG | 101790058 |
| 20220745 | 20175299 | 1.69 | 73.7 | Neo-adjuvant (N) | 2019-03-27 | 2019-03-31 | CAPECITABINE + RT | N | Y | CAPECITABINE + RT | 100231340 |
| 20220747 | 20175300 | 1.79 | 63 | null | 2017-11-04 | 2018-10-07 | Cetuximab + Oxaliplatin + MdG Maint | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101606636 |
| 20220778 | 20175301 | 1.79 | 85.9 | Disease modification (D) | 2018-09-10 | 2018-09-10 | Capecitabine 42days + RT | 02 | Y | CAPECITABINE + RT | 100854304 |
| 20220796 | 20175302 | 1.64 | 66.1 | Palliative (P) | 2017-10-25 | 2018-07-15 | EOX | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100424166 |
| 20220800 | 20175303 | 1.78 | 53.75 | Palliative (P) | 2020-02-23 | 2020-03-20 | EOX | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100941969 |
| 20220820 | 20175304 | 1.6 | 77 | Palliative (P) | 2018-11-26 | 2018-12-02 | EOX | 02 | N | CAPECITABINE + RT | 101817856 |
| 20220833 | 20175305 | 1.75 | 70.6 | Neo-adjuvant (N) | 2021-04-17 | 2021-04-24 | EOX | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 101740835 |
| 20220846 | 20175306 | 1.85 | 91.2 | Palliative (P) | 2018-10-03 | 2018-12-05 | EOX | N | N | TRIAL | 100709450 |
| 20220864 | 20175307 | 1.78 | 102 | Palliative (P) | 2018-10-20 | 2018-11-21 | EOX | 2 | N | CAPECITABINE + RT | 100086352 |
| 20220877 | 20175308 | 1.79 | 56.1 | null | 2017-10-20 | 2017-11-07 | CAPECITABINE + RT | 02 | null | CAPECITABINE + RT | 100992867 |
| 20220896 | 20175309 | 1.5 | 79.6 | Palliative (P) | 2016-11-04 | 2016-11-21 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100136464 |
| 20220920 | 20175310 | 1.58 | 66 | Palliative (P) | 2017-05-29 | 2017-06-13 | Trial Unspecified | 02 | N | TRIAL | 101122307 |
| 20220945 | 20175311 | 1.57 | 54.2 | Palliative (P) | null | 2016-09-02 | EOX | 02 | N | EOX | 100274288 |
| 20220996 | 20175312 | 0.76 | 57.4 | Palliative (P) | 2017-05-07 | 2017-05-15 | EOX | 99 | N | TRIAL | 101819144 |
| 20221057 | 20175313 | 1.9 | 78.8 | Neo-adjuvant (N) | 2020-03-28 | 2020-04-11 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100264853 |
| 20221079 | 20175314 | 1.84 | 109 | Curative (C) | 2021-05-31 | 2021-06-28 | CETUXIMAB + IRINOTECAN + MDG | 01 | Y | CETUXIMAB + IRINOTECAN + MDG | 101699760 |
| 20221095 | 20175315 | 0 | 91.4 | Palliative (P) | 2014-10-19 | 2016-08-02 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101445003 |
| 20221103 | 20175316 | 1.72 | 79.4 | null | 2016-04-28 | 2016-05-14 | EOX | N | N | TRIAL | 101482232 |
| 20221104 | 20175317 | 1.58 | 81.9 | Neo-adjuvant (N) | 2017-02-02 | 2017-05-02 | EOX | N | N | TRIAL | 100266547 |
| 20221110 | 20175318 | 1.93 | 72 | null | 2019-04-13 | 2019-04-13 | CETUXIMAB + IRINOTECAN + MDG | N | N | CETUXIMAB + IRINOTECAN + MDG | 101718312 |
| 20221118 | 20175319 | 1.88 | 75.1 | null | 2017-01-11 | 2017-01-30 | EOX | 02 | null | TRIAL | 100595490 |
| 20221140 | 20175320 | 1.44 | 72.2 | null | 2016-02-26 | 2017-02-22 | Trial Unspecified | 02 | null | TRIAL | 100709637 |
| 20221148 | 20175321 | 1.6 | 77.7 | null | 2018-06-14 | 2018-06-16 | Trial Unspecified | Y | N | TRIAL | 100887725 |
| 20221185 | 20175322 | 1.66 | 15.6 | Palliative (P) | 2017-03-23 | 2017-03-25 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101382602 |
| 20221187 | 20175323 | 1.86 | 70.3 | Palliative (P) | 2017-08-16 | 2018-04-11 | Trial Unspecified | 2 | N | TRIAL | 100101027 |
| 20221295 | 20175324 | 1.67 | 74.9 | Curative (C) | 2018-09-28 | 2018-10-22 | EOX | N | null | CAPECITABINE + RT | 101301235 |
| 20221297 | 20175325 | 1.75 | 75 | Neo-adjuvant (N) | 2018-02-14 | 2018-03-07 | EOX | Y | null | EOX | 100123939 |
| 20221300 | 20175326 | 1.75 | 62 | null | 2017-06-01 | 2019-07-14 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101375907 |
| 20221413 | 20175327 | 1.62 | 48.6 | Palliative (P) | 2017-07-14 | 2018-09-01 | EOX | N | N | CETUXIMAB + IRINOTECAN + MDG | 100575563 |
| 20221450 | 20175328 | 1.62 | 100.2 | Palliative (P) | 2018-08-16 | 2018-09-01 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 101030491 |
| 20221483 | 20175329 | 1.64 | 65.2 | Palliative (P) | 2020-07-29 | 2020-08-09 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100896888 |
| 20221496 | 20175330 | 1.83 | 74 | Palliative (P) | 2016-09-15 | 2016-09-15 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 100410223 |
| 20221557 | 20175331 | 1.83 | 52.2 | Palliative (P) | 2016-03-13 | 2016-03-27 | EOX | 02 | Y | SORAFENIB | 100470260 |
| 20221657 | 20175332 | 1.79 | 74 | null | 2019-06-12 | 2019-06-12 | EOX | 02 | null | EOX | 101042109 |
| 20221713 | 20175333 | 1.6 | 87 | Neo-adjuvant (N) | 2018-05-01 | 2018-06-26 | Trial Unspecified | 02 | N | TRIAL | 100830799 |
| 20221759 | 20175334 | 1.78 | 0 | Palliative (P) | 2018-03-23 | 2018-08-16 | EOX | 2 | N | EOX | 100398377 |
| 20221814 | 20175335 | 1.6 | 73.8 | Neo-adjuvant (N) | 2019-04-18 | 2019-04-18 | EOX | 01 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101047669 |
| 20221853 | 20175336 | 1.86 | 56.3 | null | 2018-08-10 | 2018-08-10 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100772706 |
| 20221870 | 20175337 | 1.56 | 89.3 | Palliative (P) | 2018-02-19 | 2018-05-02 | EOX | N | Y | SORAFENIB | 100876326 |
| 20221872 | 20175338 | 1.87 | 54 | Palliative (P) | 2018-05-20 | 2018-05-20 | EOX | N | N | CAPECITABINE + RT | 101483998 |
| 20221892 | 20175339 | 1.82 | 71 | Curative (C) | 2017-06-04 | 2017-06-05 | EOX | N | N | EOX | 100661654 |
| 20221911 | 20175340 | 1.72 | 86 | Curative (C) | 2016-04-16 | 2016-05-03 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100526766 |
| 20221945 | 20175341 | 1.79 | 82 | Palliative (P) | 2019-01-19 | 2019-01-19 | EOX | 02 | N | EOX | 100034724 |
| 20221947 | 20175342 | 1.7 | 54.9 | Palliative (P) | 2014-01-28 | 2014-04-08 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100612789 |
| 20221977 | 20175343 | 1.62 | 69.3 | Palliative (P) | 2016-08-20 | 2016-08-26 | Cetuximab + Oxaliplatin + MdG Maint | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100127787 |
| 20222014 | 20175344 | 0 | 52.7 | Palliative (P) | null | 2019-04-27 | Capecitabine + Mitomycin | 02 | N | CAPECITABINE + MITOMYCIN | 100735318 |
| 20222039 | 20175346 | null | null | null | null | 2019-01-31 | FLUOROURACIL + MITOMYCIN | 02 | null | FLUOROURACIL + MITOMYCIN | 101227063 |